| [1] |
侯凡凡，谢迪.慢性肾脏病应用肾素-血管紧张素系统阻断剂的治疗目标[J].中华高血压杂志，2007，15（Z1）：32-34.
|
| [2] |
Remuzzi G，Ferico N，Macia M，et al.The role of reninangiotensin-aldosterone system in the progression of chronic kidney disease[J].Kidney Int Suppl，2005，99（99）：S57-S65.
|
| [3] |
Nguyen G，Danser AH.Prorenin and（pro）renin receptor：a review of available data from in vitro studies and experimental models in rodents[J].Exp Physiol，2008，93（5）：557-563.
|
| [4] |
Oparil S，Yarows SA，Patel S，et al.Efficacy and safety of combined use of aliskiren and valsartanin patients with hypertension：a randomised，double-blind trial[J].Lancet，2007，370（9583）：221-229.
|
| [5] |
Tylicki L，Lizakowski S，Rutkowski B.Renin-angiotensin-aldosterone system blockade for nephroprotection：current evidence and future directions[J].J Nephrol，2012，25（6）：900-910.
|
| [6] |
Huang Y，Noble NA，Zhang J，et al.Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells[J].Kidney Int，2007，72（1）：45-52.
|
| [7] |
Miyata K，Satou R，Inui D，et al.Renoprotective effects of direct renin inhibition in glomerulonephritis[J].Am J Med Sci，2014，348（4）：306-314.
|
| [8] |
Nguyen G，Delarue F，Burcklé C，et al.Pivotal role of the renin/ prorenin receptor in angiotensinⅡ production and cellal responses to renin[J].J Clin Invest，2002，109（11）：1417-1427.
|
| [9] |
Feldman DL，Jin L，Xuan H，et al.Effects of aliskiren on blood pressure，albuminuria，and （pro）rennin receptor expression in diabetic TG（mRen-2）27 rats[J].Hypertension，2008，52（1）：130-136.
|
| [10] |
McMurray JJ，Abraham WT，Dickstein K，et al.Aliskiren，ALTITUDE，andtheimplicationsforatmosphere[J].EurJHeart Fail，2012，14（4）：341-343.
|
| [11] |
Heerspink HJ，Persson F，Brenner BM，et al.Renal outcomes with aliskiren in patients with type 2 diabetes：a prespecified secondary analysis of the ALTITUDE randomised controlled trial[J].Lancet Diabetes Endocrinol，2016，4（4）：309-317.
|
| [12] |
伍巧源，廖蕴华，杨桢华，等.肾素抑制剂阿利吉仑对阿霉素肾病小鼠肾损伤及足细胞nephrin表达的影响[J].西安交通大学学报（医学版），2014，35（5），665-668.
|
| [13] |
Gross O，Girgert R，Rubel D，et al.Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis[J].Am J Hypertens，2011，24（3）：355-361.
|
| [14] |
Li SY，Chen YT，Yang WC，et al.Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease[J].BMC Nephrol，2012，13（89）：1-7.
|
| [15] |
Wu MT，Tung SC，Hsu KT，et al.Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease：an open-label prospective trial[J].JRAAS，2014，15（3）：271-277.
|
| [16] |
Lopez V，Martin M，Cobelo C，et al.Reninangiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients[J].Transpl Proc，2010，42（8）：2883-2885.
|
| [17] |
Parving HH，Brenner BM，McMurray JJ，et al.Cardiorenal end points in a trial of aliskiren for type 2 diabetes[J].N Engl J Med，2012，367（23）：2204-2213.
|
| [18] |
Tang SC，Lin M，Tam S，et al.Aliskiren combined with losartan in immunoglobulin A nephropathy：an open-labeled pilot study[J].Nephrol Dial Transplant，2012，27（2）：613-618.
|
| [19] |
Szeto CC，Kwan BC，Chow KM，et al.The safety and shortterm efficacy of aliskiren in the treatment of immunoglobulin a nephropathy——a randomized cross-over study[J]. PLoS ONE，2013，8（5）：e62736.
|
| [20] |
Gupta A，Khaira A，Singh B，et al.Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy[J].Clin Exp Nephrol，2009，13（4）：402-403.
|
| [21] |
Trotter K，Clark MR，Liarski VM.Overview of pathophysiology and treatment of human lupus nephritis[J].Curr Opin Rheumatol，2016，28（5）：460-467.
|
| [22] |
Presta P，Presta P，Fuiano G，et al.Successful conception and pregnancy in p-ANCA-associated vasculitis in course of treatment with immunosuppressive drugs and renal replacement therapy[J].Int J Rheum Dis，2015，18（4）：470-472.
|
| [23] |
Yen TH，Yang HY，Yeh YH，et al.Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressureindependent mechanism[J].Lupus，2013，22（2）：180-189.
|
| [24] |
Freiberger V，Amann K，Heemann U，et al.Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation[J].Transpl Int，2009，22（11）：1110-1113.
|
| [25] |
Kumar D，Plagov A，Yadav I，et al.Inhibition of renin activity slows down the progression of HIV-associated nephropathy[J].Am J Physiol Renal Physiol，2012，303（5）：711-720.
|
| [26] |
Plagov A，Lan X，Rai P，et al.Modulation of renin angiotensin system predominantly alters sclerotic phenotype of glomeruli in HIVAN[J].Histol Histopathol，2014，29（12）：1575-1581.
|
| [27] |
Laurinavicius A，Hurwitz S，Rennke HG.Collapsing glomerulopathy in HIV and non-HIV patients：a clinicopathological and follow-up study[J].Kidney Int，1999，56（6）：2203-2213.
|
| [28] |
Kirchner JT.Resolution of renal failure after initiation of HAART：3 cases and a discussion of the literature[J].AIDS Read，2002，12（3）：103-105.
|
| [29] |
Burns GC，Paul SK，Toth IR，et al.Effect of angiotensinconverting enzyme inhibition in HIV-associated nephropathy[J].JASN，1997，8（7）：1140-1146.
|
